Fiscal year 2023 executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
Each company listed discloses CTLT in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named CTLT in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Alessandro Maselli | $925,000 | $0 | $3,850,216 | $1,650,019 | $0 | $0 | $158,437 | $6,583,672 |
| President and Chief Executive Officer | ||||||||
| John Chiminski | 700,000 | 0 | 4,000,069 | 0 | 0 | 0 | 107,698 | 4,807,767 |
| Former Executive Chair | ||||||||
| Manja Boerman | 511,387 | 0 | 2,455,217 | 195,022 | 0 | 0 | 818,262 | 3,979,888 |
| Former President, Division Head for Biomodalities | ||||||||
| Aristippos Gennadios | 600,000 | 0 | 2,700,277 | 300,017 | 135,000 | 0 | 64,263 | 3,799,557 |
| Group President, Pharma and Consumer Health | ||||||||
| Thomas Castellano | 443,654 | 0 | 875,098 | 375,003 | 0 | 0 | 1,036,228 | 2,729,983 |
| Former Senior Vice President and Chief Financial Officer | ||||||||
| Steven Fasman | 625,000 | 0 | 1,050,221 | 450,025 | 135,000 | 0 | 50,053 | 2,310,299 |
| Former Executive Vice President & Chief Administrative Officer | ||||||||
| Ricky Hopson | 380,000 | 0 | 245,150 | 105,032 | 139,500 | 0 | 102,625 | 972,307 |
| President, Division Head for Clinical Development & Supply and Former Interim Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2023 total | FY2022 total | FY2021 total | Δ FY2022→2023 |
|---|---|---|---|---|
| Alessandro Maselli | $6,583,672 | $3,234,030 | $4,559,730 | +3,349,642 |
| John Chiminski | 4,807,767 | 12,407,517 | 12,581,139 | −7,599,750 |
| Manja Boerman | 3,979,888 | — | — | — |
| Aristippos Gennadios | 3,799,557 | 2,125,504 | — | +1,674,053 |
| Thomas Castellano | 2,729,983 | 1,671,067 | 1,778,546 | +1,058,916 |
| Steven Fasman | 2,310,299 | 2,799,523 | 2,317,605 | −489,224 |
| Ricky Hopson | 972,307 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Steven Fasman | RSU | 2022-07-26 | — | — | 2,788 | — | $300,072 |
| Aristippos Gennadios | PSU | 2022-07-26 | 1,264 | 2,527 | — | 3,791 | 250,072 |
| Ricky Hopson | PSU | 2022-07-26 | 407 | 813 | — | 1,626 | 87,503 |
| Ricky Hopson | RSU | 2022-07-26 | — | — | 651 | — | 70,067 |
| Alessandro Maselli | RSU | 2022-07-26 | — | — | 10,221 | — | 1,100,086 |
| Ricky Hopson | OPTION | 2022-07-26 | — | — | 2,828 | — | 105,032 |
| Aristippos Gennadios | PSU | 2022-07-26 | 1,162 | 2,323 | — | 4,646 | 250,024 |
| Thomas Castellano | PSU | 2022-07-26 | 1,579 | 3,158 | — | 4,737 | 312,516 |
| Manja Boerman | PSU | 2022-07-26 | 822 | 1,643 | — | 2,465 | 162,591 |
| Thomas Castellano | RSU | 2022-07-26 | — | — | 2,323 | — | 250,024 |
| Steven Fasman | PSU | 2022-07-26 | 1,743 | 3,485 | — | 6,970 | 375,091 |
| Steven Fasman | PSU | 2022-07-26 | 1,895 | 3,790 | — | 5,685 | 375,058 |
| John Chiminski | RSU | 2022-07-26 | — | — | 37,165 | — | 4,000,069 |
| Steven Fasman | OPTION | 2022-07-26 | — | — | 12,117 | — | 450,025 |
| Manja Boerman | PSU | 2022-07-26 | 755 | 1,510 | — | 3,020 | 162,521 |
| Aristippos Gennadios | OPTION | 2022-07-26 | — | — | 8,078 | — | 300,017 |
| Thomas Castellano | OPTION | 2022-07-26 | — | — | 10,097 | — | 375,003 |
| Alessandro Maselli | OPTION | 2022-07-26 | — | — | 44,427 | — | 1,650,019 |
| Manja Boerman | OPTION | 2022-07-26 | — | — | 5,251 | — | 195,022 |
| Aristippos Gennadios | RSU | 2022-07-01 | — | — | 18,689 | — | 2,000,097 |
| Thomas Castellano | PSU | 2022-07-26 | 1,452 | 2,904 | — | 5,808 | 312,558 |
| Alessandro Maselli | PSU | 2022-07-26 | 6,948 | 13,895 | — | 20,843 | 1,375,049 |
| Ricky Hopson | PSU | 2022-07-26 | 443 | 885 | — | 1,328 | 87,580 |
| Aristippos Gennadios | RSU | 2022-07-26 | — | — | 1,859 | — | 200,084 |
| Alessandro Maselli | PSU | 2022-07-26 | 6,388 | 12,776 | — | 25,552 | 1,375,081 |
| Manja Boerman | PSU | 2022-07-26 | 9,292 | 18,583 | — | 37,166 | 2,000,088 |
| Manja Boerman | RSU | 2022-07-26 | — | — | 1,208 | — | 130,017 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Steven Fasman | $300,072 | $750,149 | $450,025 | 50.0% |
| Aristippos Gennadios | 2,200,181 | 500,096 | 300,017 | 16.7% |
| Ricky Hopson | 70,067 | 175,083 | 105,032 | 50.0% |
| Alessandro Maselli | 1,100,086 | 2,750,130 | 1,650,019 | 50.0% |
| Thomas Castellano | 250,024 | 625,074 | 375,003 | 50.0% |
| Manja Boerman | 130,017 | 2,325,200 | 195,022 | 87.7% |
| John Chiminski | 4,000,069 | 0 | 0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Alessandro Maselli | RSU | 10,221 | — | $17,274 |
| Alessandro Maselli | Option | 11,676 | 113 | — |
| Alessandro Maselli | Option | 3,436 | 54.94 | — |
| Alessandro Maselli | PSU | 1,949 | — | 3,294 |
| Alessandro Maselli | Option | 44,427 | 107.63 | — |
| Alessandro Maselli | RSU | 3,009 | — | 5,085 |
| Alessandro Maselli | PSU | 6,388 | — | 10,796 |
| Steven Fasman | RSU | 910,647 | — | 1,125,000 |
| Manja Boerman | RSU | 900,000 | — | 1,521,022 |
| Steven Fasman | RSU | 1,235,370 | — | 1,125,000 |
| Steven Fasman | RSU | 1,125,000 | — | 1,125,000 |
| Aristippos Gennadios | RSU | 1,372,127 | — | 1,100,000 |
| Ricky Hopson | RSU | 408,278 | — | 690,000 |
| Ricky Hopson | RSU | 319,563 | — | 690,000 |
| Ricky Hopson | PSU | 18,204 | — | 39,306 |
| Alessandro Maselli | PSU | 6,948 | — | 11,742 |
| Aristippos Gennadios | RSU | 1,100,000 | — | 881,843 |
| John Chiminski | RSU | 5,007,733 | — | 5,007,733 |
| Ricky Hopson | RSU | 690,000 | — | 1,489,847 |
| Thomas Castellano | RSU | 1,000,012 | — | 1,690,045 |
| Aristippos Gennadios | PSU | 6,155 | — | 4,934 |
| Aristippos Gennadios | RSU | 1,575,572 | — | 1,100,000 |
| Steven Fasman | RSU | 475,703 | — | 475,703 |
| Steven Fasman | PSU | 12,762 | — | 12,762 |
| Aristippos Gennadios | RSU | 301,222 | — | 301,222 |
| Alessandro Maselli | RSU | 2,838 | — | 4,796 |
| Alessandro Maselli | RSU | 3,761 | — | 6,356 |
| Alessandro Maselli | PSU | 1,881 | — | 3,179 |
| Alessandro Maselli | Option | 7,699 | 88.1 | — |
Our executive compensation program ties pay delivery to the successful execution of our overall business goals and adherence to our core values, which we believe best serves the interests of our shareholders. We believe that attracting, motivating, retaining, and rewarding superior executive talent is a key to delivering attractive shareholder returns, and that an appropriately structured executive compensation program is critical to that end, with each element supporting the achievement of our compensation philosophy.
| CEO STI target (% of salary) | 110% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Frederic W. Cook & Co., Inc. |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| J. Martin CarrollIndependent · Compensation and Leadership · Nominating and Corporate Governance · Quality and Regulatory Compliance (Chair) | $151,401 | $274,954 | $0 | — | $0 | $426,355 |
| John J. GreischEmployee director · Board Chair · Strategic and Operational Review (Chair) | 125,907 | 274,954 | 0 | — | 0 | 400,861 |
| Jack StahlIndependent · Lead Independent Director · Audit · Nominating and Corporate Governance | 120,151 | 274,954 | 0 | — | 0 | 395,105 |
| Gregory T. LucierIndependent · Audit · Compensation and Leadership (Chair) · Strategic and Operational Review | 112,651 | 274,954 | 0 | — | 0 | 387,605 |
| Rolf ClassonIndependent · Audit · Compensation and Leadership · Nominating and Corporate Governance (Chair) | 110,000 | 274,954 | 0 | — | 0 | 384,954 |
| Rosemary A. CraneIndependent · Audit | 110,000 | 274,954 | 0 | — | 0 | 384,954 |
| Donald E. Morel JrIndependent · Audit · Quality and Regulatory Compliance | 110,000 | 274,954 | 0 | — | 0 | 384,954 |
| Christa KreuzburgIndependent · Strategic and Operational Review | 100,151 | 274,954 | 0 | — | 0 | 375,105 |
| Madhavan BalachandranIndependent · Compensation and Leadership | 100,000 | 274,954 | 0 | — | 0 | 374,954 |
| Michael J. BarberIndependent · Compensation and Leadership · Nominating and Corporate Governance | 100,000 | 274,954 | 0 | — | 0 | 374,954 |
| Karen FlynnNot independent | 60,440 | 296,818 | 0 | — | 0 | 357,258 |
| Peter ZippeliusNot independent · Not standing for re-election · Departed during FY | 58,611 | 274,954 | 0 | — | 0 | 333,565 |
| Stephanie OkeyIndependent · Compensation and Leadership · Nominating and Corporate Governance · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Steven K. BargIndependent · Quality and Regulatory Compliance · Strategic and Operational Review · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| John ChiminskiEmployee director · Not standing for re-election · Departed during FY | 0 | 0 | 0 | — | 0 | 0 |
| Frank A. D'AmelioIndependent · Compensation and Leadership · Quality and Regulatory Compliance · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Alessandro MaselliEmployee director | 0 | 0 | 0 | — | 0 | 0 |
| Michelle R. RyanIndependent · Audit · Newly elected | 0 | 0 | 0 | — | 0 | 0 |
| Annual cash retainer | $100,000 |
|---|---|
| Annual equity retainer | $275,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 12,500 / 10,000 |
| Stock ownership guideline | 5x annual cash retainer |
| Component | FY2023 |
|---|---|
| Cash retainers and fees | $1,259,312 |
| Equity awards (grant-date value) | $3,321,312 |
| All other compensation | $0 |
| Total cost of the board | $4,580,624 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
Of the companies Catalent names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Catalent.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Incyte Corporation | 2025 | William Meury | $647,260 | $27,509,657 | $2,573,998 | $1,300,000 | $32,085,952 |
| 2 | Biogen Inc. | 2025 | Christopher Viehbacher | 1,727,885 | 18,368,875 | 0 | 3,190,875 | 23,646,004 |
| 3 | Boston Scientific Corporation | 2025 | Michael Mahoney | 1,442,603 | 13,608,056 | 3,749,980 | 4,002,001 | 23,532,050 |
| 4 | Vertex Pharmaceuticals Incorporated | 2025 | Reshma Kewalramani | 1,600,000 | 15,002,270 | 0 | 4,118,640 | 21,144,261 |
| 5 | Horizon Pharma plc | 2022 | Timothy Walbert | 1,292,727 | 16,601,305 | 0 | 0 | 20,103,869 |
| 6 | Align Technology, Inc. | 2025 | Joseph Hogan | 1,400,000 | 16,556,872 | 0 | 1,220,100 | 19,193,988 |
| 7 | Jazz Pharmaceuticals plc | 2025 | Renee Gala | 1,003,269 | 16,138,433 | 0 | 1,980,000 | 19,151,558 |
| 8 | The Cooper Companies, Inc. | 2025 | Albert White III | 1,170,769 | 6,642,918 | 6,643,050 | 1,525,951 | 16,051,141 |
| 9 | Hologic, Inc. | 2024 | Stephen MacMillan | 1,212,628 | 9,141,468 | 2,937,477 | 1,990,413 | 15,819,261 |
| 10 | Agilent Technologies, Inc. | 2025 | Padraig McDonnell | 1,141,345 | 8,169,850 | 2,017,759 | 1,436,809 | 12,827,236 |
| 11 | STERIS plc | 2026 | Daniel Carestio | 1,095,707 | 4,333,951 | 4,334,251 | 1,725,007 | 11,508,522 |
| 12 | Perrigo plc | 2025 | Patrick Lockwood-Taylor | 1,223,333 | 6,990,564 | 0 | 687,250 | 9,042,603 |
| 13 | Bio-Rad Laboratories, Inc. | 2025 | Norman Schwartz | 1,089,877 | 4,856,574 | 1,458,975 | 562,088 | 7,995,841 |
| 14 | West Pharmaceutical Services, Inc. | 2025 | Eric Green | 1,177,290 | 3,327,048 | 1,108,961 | 1,471,613 | 7,190,876 |
| 15 | Mettler-Toledo International Inc. | 2025 | Patrick Kaltenbach | 1,145,999 | 3,267,808 | 1,635,033 | 462,984 | 6,741,212 |
| 16 | Catalent | 2023 | Alessandro Maselli | 925,000 | 3,850,216 | 1,650,019 | 0 | 6,583,672 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Catalent | 0% | PSU 50 · Options 30 · RSU 20 | No | Frederic W. Cook & Co., Inc. |
| Agilent Technologies, Inc. | not disclosed | PSU 60 · Options 20 · RSU 20 | No | Semler Brossy |
| Align Technology, Inc. | 58.1% | MSU 70 · RSU 30 | Yes — Relative Total Stockholder Return (TSR) vs. Nasdaq Composite Index | Compensia, Inc. |
| Bio-Rad Laboratories, Inc. | not disclosed | not disclosed | not disclosed | Compensia, Inc. |
| Biogen Inc. | 127% | PSU 60 · RSU 40 | Yes | Pay Governance |
| Boston Scientific Corporation | 173% | PSU 50 · RSU 25 · Options 25 | No | Semler Brossy Consulting Group, LLC |
| Hologic, Inc. | 109% | PSU 50 · RSU 25 · Options 25 | No | not disclosed |
| Horizon Pharma plc | 100% | RSU 50 · PSU 50 | Yes — Relative TSR | Aon plc (Human Capital Solutions practice) |
| Incyte Corporation | 138.6% | PSU 60 · Options 20 · RSU 20 | Yes — relative total shareholder return (TSR) | Aon |
| Jazz Pharmaceuticals plc | 150% | PSU 50 · RSU 50 | Yes — Relative TSR | Aon |
| Mettler-Toledo International Inc. | 80% | PSU 33 · RSU 33 · Options 33 | Yes — Relative Total Shareholder Return (rTSR) | Pearl Meyer & Partners (PM&P) |
| Perrigo plc | 44.3% | PSU 70 · RSU 30 | Yes — Relative TSR (rTSR) | FW Cook |
| STERIS plc | 125.1% | RSU 50 · Options 50 | not disclosed | Frederic W. Cook & Co., Inc. |
| The Cooper Companies, Inc. | 100.9% | Options 50 · PSU 50 | No | Compensia |
| Vertex Pharmaceuticals Incorporated | not disclosed | PSU 55 · RSU 45 | No | not disclosed |
| West Pharmaceutical Services, Inc. | 100% | PSU 50 · RSU 25 · Options 25 | No | Pay Governance |
Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Alessandro Maselli | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 6,583,672. Filing ↗machine: t161 · r3 · c31 · span 1055835–1055844 |
| 2 | Section 01, John Chiminski | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 4,807,767. Filing ↗machine: t17 · r10 · c19 · span 206903–206912 |
| 3 | Section 01, Manja Boerman | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 3,979,888. Filing ↗machine: t17 · r11 · c19 · span 210711–210720 |
| 4 | Section 01, Aristippos Gennadios | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 3,799,557. Filing ↗machine: t161 · r19 · c31 · span 1110488–1110497 |
| 5 | Section 01, Thomas Castellano | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 2,729,983. Filing ↗machine: t161 · r7 · c31 · span 1070604–1070613 |
| 6 | Section 01, Steven Fasman | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 2,310,299. Filing ↗machine: t17 · r8 · c19 · span 199523–199532 |
| 7 | Section 01, Ricky Hopson | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Summary Compensation Table”. As printed: 972,307. Filing ↗machine: t161 · r11 · c31 · span 1084097–1084104 |
| 8 | Section 03, Steven Fasman RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r20 · c34 · span 1361508–1361513 |
| 9 | Section 03, Aristippos Gennadios PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r29 · c26 · span 1422393–1422398 |
| 10 | Section 03, Ricky Hopson PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r16 · c26 · span 1329263–1329266 |
| 11 | Section 03, Ricky Hopson RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r15 · c34 · span 1323257–1323260 |
| 12 | Section 03, Alessandro Maselli RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r5 · c34 · span 1246799–1246805 |
| 13 | Section 03, Ricky Hopson OPTION | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r14 · c38 · span 1316614–1316619 |
| 14 | Section 03, Aristippos Gennadios PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r28 · c26 · span 1415154–1415159 |
| 15 | Section 03, Thomas Castellano PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r12 · c26 · span 1298328–1298333 |
| 16 | Section 03, Manja Boerman PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r36 · c27 · span 1477411–1477416 |
| 17 | Section 03, Thomas Castellano RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r10 · c34 · span 1285078–1285083 |
| 18 | Section 03, Steven Fasman PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r21 · c26 · span 1367519–1367524 |
| 19 | Section 03, Steven Fasman PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r22 · c26 · span 1374758–1374763 |
| 20 | Section 03, John Chiminski RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r31 · c34 · span 1440053–1440059 |
| 21 | Section 03, Steven Fasman OPTION | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r19 · c38 · span 1354864–1354870 |
| 22 | Section 03, Manja Boerman PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r35 · c27 · span 1470064–1470069 |
| 23 | Section 03, Aristippos Gennadios OPTION | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r26 · c38 · span 1402500–1402505 |
| 24 | Section 03, Thomas Castellano OPTION | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r9 · c38 · span 1278434–1278440 |
| 25 | Section 03, Alessandro Maselli OPTION | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r4 · c38 · span 1240153–1240159 |
| 26 | Section 03, Manja Boerman OPTION | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r33 · c38 · span 1457192–1457197 |
| 27 | Section 03, Aristippos Gennadios RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r25 · c34 · span 1394559–1394565 |
| 28 | Section 03, Thomas Castellano PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r11 · c26 · span 1291089–1291094 |
| 29 | Section 03, Alessandro Maselli PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r7 · c26 · span 1260056–1260062 |
| 30 | Section 03, Ricky Hopson PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r17 · c26 · span 1336497–1336500 |
| 31 | Section 03, Aristippos Gennadios RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r27 · c34 · span 1409143–1409148 |
| 32 | Section 03, Alessandro Maselli PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r6 · c26 · span 1252813–1252819 |
| 33 | Section 03, Manja Boerman PSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r37 · c27 · span 1485927–1485933 |
| 34 | Section 03, Manja Boerman RSU | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Fiscal 2023 Grants of Plan-Based Awards Table” · grants of plan-based awards table. Filing ↗machine: t184 · r34 · c35 · span 1463945–1463950 |
| 35 | Section 08, J. Martin Carroll | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 426,355. Filing ↗machine: t107 · r4 · c11 · span 696988–696995 |
| 36 | Section 08, John J. Greisch | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 400,861. Filing ↗machine: t107 · r8 · c11 · span 706619–706626 |
| 37 | Section 08, Jack Stahl | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 395,105. Filing ↗machine: t107 · r12 · c11 · span 716107–716114 |
| 38 | Section 08, Gregory T. Lucier | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 387,605. Filing ↗machine: t107 · r10 · c11 · span 711370–711377 |
| 39 | Section 08, Rolf Classon | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 384,954. Filing ↗machine: t107 · r5 · c11 · span 699395–699402 |
| 40 | Section 08, Rosemary A. Crane | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 384,954. Filing ↗machine: t107 · r6 · c11 · span 701804–701811 |
| 41 | Section 08, Donald E. Morel Jr | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 384,954. Filing ↗machine: t107 · r11 · c11 · span 713705–713712 |
| 42 | Section 08, Christa Kreuzburg | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 375,105. Filing ↗machine: t107 · r9 · c11 · span 708951–708958 |
| 43 | Section 08, Madhavan Balachandran | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 374,954. Filing ↗machine: t107 · r2 · c11 · span 692247–692254 |
| 44 | Section 08, Michael J. Barber | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 374,954. Filing ↗machine: t107 · r3 · c11 · span 694656–694663 |
| 45 | Section 08, Karen Flynn | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 357,258. Filing ↗machine: t107 · r7 · c11 · span 704206–704213 |
| 46 | Section 08, Peter Zippelius | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 333,565. Filing ↗machine: t107 · r13 · c11 · span 718513–718520 |
| 47 | Section 08, Stephanie Okey | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 48 | Section 08, Steven K. Barg | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 49 | Section 08, John Chiminski | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 50 | Section 08, Frank A. D'Amelio | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 51 | Section 08, Alessandro Maselli | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 52 | Section 08, Michelle R. Ryan | DEF 14A | 2023-12-15 | 0001193125-23-295996 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 53 | Section 01 trend, Δ column (computed) | Computed | — | computed | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 54 | Section 03b vehicle mix (computed) | Computed | — | computed | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 55 | Section 09b board cost (computed) | Computed | — | computed | Cash 1,259,312 + equity 3,321,312 + all other 0 = 4,580,624, summed across the director compensation table rows.machine: formula: Σ = 4,580,624 |
| 56 | Incyte Corporation, Section 10b CEO total | DEF 14A | 2026-04-28 | 0000879169-26-000031 | CEO total compensation as printed in Incyte Corporation's own proxy. As printed: 32,085,952. Filing ↗machine: t91 · r2 · c16 · span 637817–637827 |
| 57 | Biogen Inc., Section 10b CEO total | DEF 14A | 2026-04-28 | 0001193125-26-187303 | CEO total compensation as printed in Biogen Inc.'s own proxy. As printed: 23,646,004. Filing ↗machine: r2 · c16 · span 1174380–1174391 |
| 58 | Boston Scientific Corporation, Section 10b CEO total | DEF 14A | 2026-03-18 | 0000885725-26-000025 | CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. Filing ↗machine: r2 · c27 · span 1249807–1249817 |
| 59 | Vertex Pharmaceuticals Incorporated, Section 10b CEO total | DEF 14A | 2026-04-02 | 0000875320-26-000153 | CEO total compensation as printed in Vertex Pharmaceuticals Incorporated's own proxy. As printed: 21,144,261. Filing ↗machine: r2 · c13 · span 2942799–2942809 |
| 60 | Horizon Pharma plc, Section 10b CEO total | DEF 14A | 2023-06-30 | 0001193125-23-180318 | CEO total compensation as printed in Horizon Pharma plc's own proxy. As printed: 20,103,869. Filing ↗machine: t304 · r4 · c27 · span 746414–746424 |
| 61 | Align Technology, Inc., Section 10b CEO total | DEF 14A | 2026-04-07 | 0001097149-26-000023 | CEO total compensation as printed in Align Technology, Inc.'s own proxy. As printed: 19,193,988. Filing ↗machine: r2 · c42 · span 933168–933178 |
| 62 | Jazz Pharmaceuticals plc, Section 10b CEO total | DEF 14A | 2026-06-08 | 0001232524-26-000029 | CEO total compensation as printed in Jazz Pharmaceuticals plc's own proxy. As printed: 19,151,558. Filing ↗machine: r3 · c27 · span 1437369–1437379 |
| 63 | The Cooper Companies, Inc., Section 10b CEO total | DEF 14A | 2026-02-24 | 0001628280-26-011110 | CEO total compensation as printed in The Cooper Companies, Inc.'s own proxy. As printed: 16,051,141. Filing ↗machine: t120 · r3 · c14 · span 744904–744914 |
| 64 | Hologic, Inc., Section 10b CEO total | DEF 14A | 2025-01-16 | 0001140361-25-001287 | CEO total compensation as printed in Hologic, Inc.'s own proxy. As printed: 15,819,261. Filing ↗machine: r2 · c25 · span 1549664–1549674 |
| 65 | Agilent Technologies, Inc., Section 10b CEO total | DEF 14A | 2026-02-06 | 0001193125-26-040286 | CEO total compensation as printed in Agilent Technologies, Inc.'s own proxy. As printed: 12,827,236. Filing ↗machine: r3 · c29 · span 1450982–1450992 |
| 66 | STERIS plc, Section 10b CEO total | DEF 14A | 2026-06-11 | 0001193125-26-267599 | CEO total compensation as printed in STERIS plc's own proxy. As printed: 11,508,522. Filing ↗machine: t172 · r6 · c34 · span 820590–820600 |
| 67 | Perrigo plc, Section 10b CEO total | DEF 14A | 2026-03-20 | 0001585364-26-000024 | CEO total compensation as printed in Perrigo plc's own proxy. As printed: 9,042,603. Filing ↗machine: r3 · c12 · span 2143273–2143282 |
| 68 | Bio-Rad Laboratories, Inc., Section 10b CEO total | DEF 14A | 2026-03-25 | 0000012208-26-000020 | CEO total compensation as printed in Bio-Rad Laboratories, Inc.'s own proxy. As printed: 7,995,841. Filing ↗machine: r2 · c24 · span 654200–654209 |
| 69 | West Pharmaceutical Services, Inc., Section 10b CEO total | DEF 14A | 2026-03-12 | 0001104659-26-026778 | CEO total compensation as printed in West Pharmaceutical Services, Inc.'s own proxy. As printed: 7,190,876. Filing ↗machine: t165 · r7 · c18 · span 1241781–1241790 |
| 70 | Mettler-Toledo International Inc., Section 10b CEO total | DEF 14A | 2026-03-18 | 0001174947-26-000389 | CEO total compensation as printed in Mettler-Toledo International Inc.'s own proxy. As printed: 6,741,212. Filing ↗machine: r2 · c7 · span 643529–643538 |
| 71 | Catalent (subject), Section 10b CEO total | DEF 14A | 2023-12-15 | 0001193125-23-295996 | CEO total compensation as printed in Catalent's own proxy. As printed: 6,583,672. Filing ↗machine: t161 · r3 · c31 · span 1055835–1055844 |
| 72 | Section 10a, Perrigo plc reciprocity | DEF 14A | — | 0001585364-26-000024 | Perrigo plc's most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 73 | Section 10a, West Pharmaceutical Services, Inc. reciprocity | DEF 14A | — | 0001104659-26-026778 | West Pharmaceutical Services, Inc.'s most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 74 | Section 10a, Align Technology, Inc. reciprocity | DEF 14A | — | 0001097149-26-000023 | Align Technology, Inc.'s most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 75 | Section 10a, Jazz Pharmaceuticals plc reciprocity | DEF 14A | — | 0001232524-26-000029 | Jazz Pharmaceuticals plc's most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 76 | Section 10a, The Cooper Companies, Inc. reciprocity | DEF 14A | — | 0001628280-26-011110 | The Cooper Companies, Inc.'s most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 77 | Section 10a, Vertex Pharmaceuticals Incorporated reciprocity | DEF 14A | — | 0000875320-26-000153 | Vertex Pharmaceuticals Incorporated's most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 78 | Section 10a, Agilent Technologies, Inc. reciprocity | DEF 14A | — | 0001193125-26-040286 | Agilent Technologies, Inc. names Catalent in its own disclosed peer group (read from its most recent proxy). Filing ↗ |
| 79 | Section 10a, Boston Scientific Corporation reciprocity | DEF 14A | — | 0000885725-26-000025 | Boston Scientific Corporation's most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 80 | Section 10a, Hologic, Inc. reciprocity | DEF 14A | — | 0001140361-25-001287 | Hologic, Inc.'s most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 81 | Section 10a, Horizon Pharma plc reciprocity | DEF 14A | — | 0001193125-23-180318 | Horizon Pharma plc's most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 82 | Section 10a, Mettler-Toledo International Inc. reciprocity | DEF 14A | — | 0001174947-26-000389 | Mettler-Toledo International Inc.'s most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |
| 83 | Section 10a, STERIS plc reciprocity | DEF 14A | — | 0001193125-26-267599 | STERIS plc's most recent proxy was read; its disclosed peer group does not include Catalent. Filing ↗ |